- Home
- GLOB vs CVKD Comparison
GLOB vs CVKD Comparison
Compare GLOB & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLOB
- CVKD
- Stock Information
- Founded
- GLOB 2003
- CVKD 2022
- Country
- GLOB Luxembourg
- CVKD United States
- Employees
- GLOB N/A
- CVKD N/A
- Industry
- GLOB EDP Services
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- GLOB Technology
- CVKD Health Care
- Exchange
- GLOB Nasdaq
- CVKD Nasdaq
- Market Cap
- GLOB N/A
- CVKD 31.5M
- IPO Year
- GLOB 2014
- CVKD 2023
- Fundamental
- Price
- GLOB $107.30
- CVKD $15.29
- Analyst Decision
- GLOB Buy
- CVKD Strong Buy
- Analyst Count
- GLOB 18
- CVKD 1
- Target Price
- GLOB $218.89
- CVKD $32.00
- AVG Volume (30 Days)
- GLOB 1.0M
- CVKD 29.6K
- Earning Date
- GLOB 05-15-2025
- CVKD 05-08-2025
- Dividend Yield
- GLOB N/A
- CVKD N/A
- EPS Growth
- GLOB 2.20
- CVKD N/A
- EPS
- GLOB 3.72
- CVKD N/A
- Revenue
- GLOB $2,415,689,000.00
- CVKD N/A
- Revenue This Year
- GLOB $12.89
- CVKD N/A
- Revenue Next Year
- GLOB $13.93
- CVKD N/A
- P/E Ratio
- GLOB $27.03
- CVKD N/A
- Revenue Growth
- GLOB 15.26
- CVKD N/A
- 52 Week Low
- GLOB $96.23
- CVKD $5.40
- 52 Week High
- GLOB $238.32
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- GLOB 26.87
- CVKD 34.88
- Support Level
- GLOB $96.23
- CVKD $14.05
- Resistance Level
- GLOB $119.52
- CVKD $19.03
- Average True Range (ATR)
- GLOB 6.01
- CVKD 1.22
- MACD
- GLOB -0.01
- CVKD -0.42
- Stochastic Oscillator
- GLOB 30.15
- CVKD 21.62
Stock Price Comparison Chart: GLOB vs CVKD
■ GLOB
■ CVKD
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.